HR 890
Stopping Pharma’s Ripoffs and Drug Savings For All Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 6:35 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Stopping Pharma’s Ripoffs and Drug Savings For All Act, aims to prevent pharmaceutical companies from obtaining multiple patents for the same drug. It requires patent holders to prove that each patent covers a distinct invention when listing multiple patents for a drug. If they fail to demonstrate distinct inventions, the patents will be automatically disclaimed after the first patent’s term expires. The bill also directs the USPTO to review its examination procedures to prevent the issuance of overlapping patents for the same drug or biological product.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.